ACM
BHVN icon

Atika Capital Management’s Biohaven BHVN Stock Holding History

Atika Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-37,500
Closed -$2.05M – 94
2024
Q1 		$2.05M Buy
+37,500
New +$1.86M 0.2% 83
2023
Q1 		– Sell
-238,413
Closed -$3.31M – 79
2022
Q4 		$3.31M Buy
+238,413
New +$3.37M 0.48% 52

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Atika Capital Management's BHVN Position: Q2 2024 in Review

Atika Capital Management sold out of Biohaven (BHVN) in Q2 2024, closing a stake of 37,500 shares — an estimated $2.05M sold.

Atika Capital Management first reported a position in BHVN in Q4 2022 and held it in 2 quarters. The position peaked at $3.31M in Q4 2022. 225 funds tracked by Wall St. Rank hold BHVN as of Q2 2024.

  • Atika Capital Management reported no remaining Biohaven position as of Q2 2024 after selling out during the quarter.
  • Atika Capital Management sold 37,500 Biohaven shares in Q2 2024, an estimated $2.05M.
  • Atika Capital Management first reported a position in Biohaven in Q4 2022 and held it in 2 quarters.
  • Atika Capital Management's Biohaven position peaked at $3.31M in Q4 2022.
  • 225 funds tracked by Wall St. Rank held Biohaven as of Q2 2024.

Based on Atika Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.